GO Term |
---|
CMP-N-acetylneuraminate transmembrane transport |
carbohydrate metabolic process |
protein modification process |
GO Term |
---|
Golgi membrane |
Golgi apparatus |
plasma membrane |
membrane |
GO Term |
---|
antiporter activity |
CMP-N-acetylneuraminate transmembrane transporter activity |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
|
Pathway Name | Organism |
---|---|
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) | Homo sapiens |
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) | Homo sapiens |
Sialic acid metabolism | Homo sapiens |
Transport of nucleotide sugars | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:381 | arthropathy | |
DOID:0050571 | congenital disorder of glycosylation type II | |
DOID:0050572 | cone-rod dystrophy | |
DOID:0050589 | inflammatory bowel disease | |
DOID:0050590 | severe congenital neutropenia | |
DOID:0050759 | myotonic dystrophy type 2 | |
DOID:0070258 | congenital disorder of glycosylation type IIf | |
DOID:0080348 | Alzheimer's disease 1 | |
DOID:0080568 | congenital disorder of glycosylation Iq | |
DOID:0090053 | episodic kinesigenic dyskinesia 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024